1476-5381/asset/olbannerleft.gif?v=1&s=198ba9e64c782a75183a18cb494f9d10ecc901ea)
1476-5381/asset/olbannerright.gif?v=1&s=0b2124237bd4227e7991f1ea05cd4bed2496a9ae)
You have full text access to this OnlineOpen article
Differential effects of nitric oxide synthase inhibitors on endothelium-dependent and nitrergic nerve-mediated vasodilatation in the bovine ciliary artery
Article first published online: 29 JAN 2009
DOI: 10.1038/sj.bjp.0707113
2007 British Pharmacological Society
1476-5381/asset/cover.gif?v=1&s=f56f5a76559ff1cebf2b6e329fe028f1e9e0f463 "British Journal of Pharmacology")
Additional Information
How to Cite
Overend, J. and Martin, W. (2007), Differential effects of nitric oxide synthase inhibitors on endothelium-dependent and nitrergic nerve-mediated vasodilatation in the bovine ciliary artery. British Journal of Pharmacology, 150: 488–493. doi: 10.1038/sj.bjp.0707113
Publication History
- Issue published online: 29 JAN 2009
- Article first published online: 29 JAN 2009
- (Received September 15, 2006, Revised October 26, 2006, Accepted November 17, 2006)
References
- , (1992). NG-monomethyl-L-arginine causes nitric oxide synthesis in isolated arterial rings: trouble in paradise. Biochem Biophys Res Commun 188: 590–596.
- , , (1993). Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine. Br J Pharmacol 110: 1003–1008.
- , (1995). Inhibition of constitutive and inducible nitric-oxide synthase: potential selective inhibition. Annu Rev Pharmacol Toxicol 35: 165–194.
- , , , (2001). Reduced amide bond peptidomimetics. (4S)-N-(4-amino-5-[aminoalkyl]aminopentyl)-N′-nitroguanidines, potent and highly selective inhibitors of neuronal nitric oxide synthase. J Med Chem 44: 2667–2670.
- , , (1987). Macrophage cytotoxicity–role for L-arginine deiminase and imino-nitrogen oxidation to nitrite. Science 235: 473–476.
- , , (1999). Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol 39: 191–220.
- (1999). Functional role of nitric oxide in regulation of ocular blood flow. Eur J Pharmacol 374: 161–174.
- , (2005). Structure–function studies on nitric oxide synthases. J Inorganic Biochem 99: 293–305.
- , , , (1991). Effects of NG-substituted analogues of L-arginine on NANC relaxation of the rat anococcygeus and bovine retractor penis muscles and the bovine penile artery. Br J Pharmacol 104: 53–58.
- , , (1993). Actions and interactions of NG-substituted analogues of L-arginine on NANC neurotransmission in the bovine retractor penis and rat anococcygeus muscles. Br J Pharmacol 108: 242–247.
- , , , , (2003). Differential effects of ascorbate on endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation in the bovine ciliary vascular bed and coronary artery. Br J Pharmacol 138: 1172–1180.
- , , , , (1990). -NG-nitro-arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent relaxation in vitro. Br J Pharmacol 99: 408–412.
- , , , , , et al. (1996). Inhibitors of human nitric oxide synthase isoforms with the carbamidine moiety as a common structural element. Bioorg Med Chem 4: 1559–1564.
- , , , , , (1991). Acetylcholine-induced vasodilatation in rabbit hindlimb in vivo is not inhibited by analogues of arginine. Am J Physiol 260: H242–H247.
- , (1993). NG-monomethyl-L-arginine functions as an alternative substrate and mechanism-based inhibitor of nitric oxide synthase. Biochemistry 32: 9677–9685.
- , , (2005). Biphasic neurogenic vasodilatation in the bovine intraocular long posterior ciliary artery: involvement of nitric oxide and an additional unidentified neurotransmitter. Br J Pharmacol 145: 1001–1008.
- , , , (1989). A specific inhibitor of nitric oxide formation form L-arginine attenuates endothelium-dependent relaxations. Br J Pharmacol 96: 418–424.
- , , , , (1990). Characterisation of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101: 746–752.
- , , (2000). EDHF, NO and a prostanoid: hyperpolarization-dependent and -independent relaxation in guinea pig arteries. Br J Pharmacol 130: 605–618.
- , (2003). The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol Rev 55: 271–324.
- , (1994). Effect of potassium channel blockers on L-NAME insensitive relaxations in rat small mesenteric artery. Can J Physiol Pharmacol 72: 11.
- , , , (1994). Nonadrenergic noncholinergic vasodilatation in bovine ciliary artery involves CGRP and neurogenic nitric oxide. Invest Opthalmol Vis Sci 35: 3268–3277.
- , , , , , (1997a). Mechanism of inactivation of neuronal nitric oxide synthase by Nω-allyl-L-arginine. J Am Chem Soc 119: 10888–10902.
- , , , , (1997b). Potent and selective inhibition of neuronal nitric oxide synthase by Nω-propyl-L-arginine. J Med Chem 40: 3869–3870.
- , (1996). Role of potassium channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery. Br J Pharmacol 117: 1600–1606.